Ryan & Maniskas, LLP Announces Investigation of SenoRx, Inc.
May 05 2010 - 6:17PM
Business Wire
Ryan & Maniskas, LLP (www.rmclasslaw.com/cases/senorx) has
commenced an investigation into possible breaches of fiduciary duty
and other violations of state law by members of the Board of
Directors of SenoRx, Inc. (“SenoRx” or the “Company”) (NASDAQ:SENO)
in connection with their actions in causing SenoRx to enter into a
merger agreement with C. R. Bard, Inc.
Our investigation concerns possible breaches of fiduciary duty
and other violations of law related to approval of the transaction
by Company’s board of directors; in particular, whether the Company
undertook a fair process to obtain fair consideration for all
shareholders of SenoRx. For more information regarding our
investigation please contact Richard A. Maniskas, Esquire
toll-free: (877) 316-3218 or visit:
www.rmclasslaw.com/cases/senorx.
Under the terms of the merger agreement, SenoRx shareholders
will receive $11 in cash for each share that they hold at the
closing of the merger.
If you own shares of SenoRx and would like to learn more about
these claims or if you wish to discuss these matters and have any
questions concerning this announcement or your rights, contact
Richard A. Maniskas, Esquire toll-free: (877) 316-3218 or visit:
www.rmclasslaw.com/cases/senorx. You may also email Mr. Maniskas at
rmaniskas@rmclasslaw.com. For more information about class action
cases in general, please visit our website: www.rmclasslaw.com.
Ryan & Maniskas, LLP is a national shareholder litigation
firm. Ryan and Maniskas, LLP is devoted to protecting the interests
of individual and institutional investors in shareholder actions in
state and federal courts nationwide.
Senorx (MM) (NASDAQ:SENO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Senorx (MM) (NASDAQ:SENO)
Historical Stock Chart
From Jul 2023 to Jul 2024